Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROCK-ABC intraocular pressure lowering study
jRCTs031240193Active, not recruiting
- Sponsor
- Kowa Company, Ltd.
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in open-angle glaucoma (OAG) and ocular hypertension comparing ripasudil + brimonidine fixed-dose combination with dorzolamide + timolol fixed-dose combination (2 arms). Primary endpoint: Change in intraocular pressure at 2 hours post-instillation. Started Aug 2024; status: active, not recruiting.
02
Drugs
ripasudilbrimonidinedorzolamidetimolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on jRCTs031240193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240193.